Ranbaxy Laboratories Limited Stock

Stocks

End-of-day quote NSE India S.E.
- ^INR	-

07/03/16	UCB : Pharma crusader takes India's drug regulators to court	RE
29/06/15	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE

07/03/16	UCB : Pharma crusader takes India's drug regulators to court	RE
29/06/15	Aurobindo Pharma : Indian pharma's struggle to tighten standards paves way for M&A deals	RE
20/04/15	DAIICHI SANKYO : Japan's Daiichi Sankyo to sell up to $3.6 billion Sun Pharma stake	RE
30/01/15	DAIICHI SANKYO : Sun Pharmaceutical wins U.S. approval to buy Ranbaxy	RE
05/12/14	AstraZeneca : Ranbaxy prevail in Nexium antitrust trial	RE
20/11/14	AstraZeneca : U.S. court denies Ranbaxy's bid to block launch of rival generics	RE
18/11/14	AstraZeneca : Ranbaxy sues FDA over revoking approvals for Nexium, Valcyte copies	RE
28/10/14	GlaxoSmithKline : Novartis results top forecasts as new products gain momentum	RE
31/07/14	AbbVie : AstraZeneca raises forecasts after seeing off Pfizer	RE
25/07/14	AbbVie : AstraZeneca results to get lift from bid foe Pfizer	RE
17/07/14	Novartis : Drugmaker Novartis to eke out more cost savings to lift margins	RE
24/06/14	Abbott India : Exclusive - India likely to extend price caps to more drugs: sources	RE
19/06/14	Mylan : EU to fine Servier, Teva for delaying generic drugs - sources	RE

04/03/15	Ranbaxy Laboratories : & APICON BREAK GUINNESS WORLD RECORD™	PU
28/01/15	Ranbaxy Laboratories : Q3FY 2015 Sales Rs.25,876Mn. YTD Dec’14 Sales Rs.81,778Mn	PU
06/12/14	Ranbaxy Laboratories : launches Red Heart Initiative to Raise Awareness on Women Heart Health	PU
01/12/14	Ranbaxy Laboratories : launches India’s first biosimilar of Infliximab drug, Infimab™	PU
29/07/14	Ranbaxy Laboratories : Q1 FY 2015 (Apr’14-Jun’14) Sales Rs.23.7 Bn	PU

17/07/14	Novartis : confirme l'objectif de croissance de ses ventes
17/07/14	Novartis : confirme l'objectif de croissance du C.A. annuel
19/06/14	Servier, Teva, d'autres à l'amende pour du "pay-for-delay"-sces
22/04/14	S& 500 : Vague de fusions dans le domaine de la pharmacie
07/04/14	Sun Pharmaceutical : Inde/Génériques-Sun Pharma acquiert Ranbaxy pour $3,2 mds

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ELI LILLY AND COMPANY	-1.64%	+1.16%	+54.09%	+109.07%	1,026B
JOHNSON & JOHNSON	-0.01%	+0.71%	+52.44%	+67.71%	649B
ABBVIE INC.	-0.05%	+0.98%	+19.08%	+73.55%	468B
ROCHE HOLDING AG	-0.21%	+0.36%	+39.48%	+45.26%	352B
NOVARTIS AG	+0.75%	+2.14%	+21.13%	+28.11%	271B
ASTRAZENECA PLC	-0.35%	-0.34%	+10.49%	+10.65%	256B
AMGEN INC.	-1.01%	+7.90%	+41.59%	+51.70%	220B
GILEAD SCIENCES, INC.	-0.85%	+2.50%	+32.32%	+101.80%	188B
NOVO NORDISK A/S	-1.71%	-11.06%	-33.13%	-61.01%	170B
Average	-0.20%	+1.26%	+26.39%	+47.43%	399.9B
Weighted average by Cap.	-0.09%	+1.26%	+36.21%	+65.75%